Impact of ribavirin dose on retreatment of chronic hepatitis C patients

AIM: To study the efficacy and factors associated with a sustained virological response (SVR) in chronic hepatitis C (CHC) relapsing patients. METHODS: Out of 1228 CHC patients treated with pegylated interferon (PEG-IFN) and ribavirin (RBV), 165 (13%) had a relapse. Among these, 62 patients were ret...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Stern, Christiane, Martinot-Peignoux, Michelle, Ripault, Marie Pierre, Boyer, Nathalie, Castelnau, Corinne, Valla, Dominique, Marcellin, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Co., Limited 2012
Soggetti:
Brief Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3380324/
https://ncbi.nlm.nih.gov/pubmed/22736920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i23.2966
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi